Table 3

Reduction in incidence and mortality for haemorrhagic stroke due to 30% reduction in salt intake in the 2016 adult Cameroonian population

Year(s)Haemorrhagic stroke
MaleFemaleTotal
Incidencen (95% UI)% (95% UI)n (95% UI)% (95% UI)n (95% UI)% (95% UI)
Year 1 to 5
2016–2020
1400 (1200–1600)10.6 (9.0–12.4)1100 (900–1200)8.4 (7.4–9.5)2500 (2200–2800)9.5 (8.3–10.9)
Year 1 to 10
2016–2025
2900 (2500–3400)10.5 (9.0–12.1)2200 (2000–2500)8.3 (7.5–9.3)5200 (4600–5800)9.4 (8.4–10.6)
Year 1 to 15
2016–2030
4600 (4000–5200)10.4 (9.0–11.8)3500 (3200–3800)8.2 (7.5–9.0)8100 (7300–9000)9.3 (8.4–10.4)
Year 1 to 20
2016–2035
6200 (5400–7100)10.1 (8.8–11.5)4800 (4500–5200)8.1 (7.4–8.7)11 100 (10 000–12 300)9.1 (8.2–10.1)
Year 1 to 25
2016–2040
7700 (6600–8800)9.7 (8.4–11.2)6100 (5600–6600)7.8 (7.2–8.4)13 800 (12 400–15 300)8.8 (7.9–9.7)
Year 1 to 30
2016–2045
8900 (7700–10 300)9.3 (8.0–10.7)7200 (6600–7700)7.4 (6.9–8.0)16 100 (14 500–17 800)8.4 (7.6–9.3)
Lifetime11 100 (9300–13 000)7.6 (6.4–8.8)9400 (8600–10 200)5.8 (5.3–6.2)20 500 (18 200–23 000)6.6 (5.9–7.4)
Mortality
Year 1 to 5
2016–2020
570 (480–670)10.4 (8.8–12.3)400 (360–470)8.0 (6.9–9.1)1000 (800–1100)9.3 (8.0–10.7)
Year 1 to 10
2016–2025
1800 (1500–2100)10.6 (9.0–12.2)1300 (1200–1500)8.2 (7.3–9.2)3100 (2700–3500)9.5 (8.3–10.7)
Year 1 to 15
2016–2030
3200 (2800–3700)10.6 (9.2–12.1)2400 (2200–2600)8.3 (7.5–9.1)5600 (5000–6200)9.5 (8.5–10.6)
Year 1 to 20
2016–2035
4700 (4100–5400)10.5 (9.111.9)3600 (3300–3900)8.2 (7.6–8.9)8300 (7400–9100)9.4 (8.4–10.4)
Year 1 to 25
2016–2040
6100 (5300–7000)10.2 (8.8–11.6)4700 (4400–5100)8.0 (7.4–8.7)10 800 (9800–12 000)9.2 (8.3–10.1)
Year 1 to 30
2016–2045
7300 (6300–8400)9.8 (8.4–11.2)5800 (5300–6200)7.7 (7.2–8.3)13 100 (11 800–14 500)8.8 (7.9–9.7)
Lifetime9600 (8100–11 200)7.9 (6.6–9.2)8100 (7400–8800)6.0 (5.5–6.4)17 700 (15 700–19 800)6.9 (6.1–7.7)
  • UI, uncertainty interval.